Farmakoekonomika

SJR Rank #24,698H-index: 11SJR: 0.159Best quartile: Q4Open AccessAPC: US$142Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

IRBIS LLC

Country

Russian Federation

Type

journal

SJR by Edition

2022202500.040.080.120.16

Subject Categories

  • Health PolicyQ4
  • PharmacologyQ4
  • Public Health, Environmental and Occupational HealthQ4

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Healthcare Systems and Public HealthHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic, Social, and Public Health Issues in Russia and GloballyEconomic and Financial Impacts of CancerArtificial Intelligence in Healthcare and EducationRespiratory and Cough-Related ResearchHuman Health and DiseaseComputational Drug Discovery MethodsPharmaceutical studies and practices

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

20222025015304560

Detailed Information

ISSN

2070-4933, 2070-4909

SJR Best Quartile

Q4

Region

Eastern Europe

Citations per Document (2 years)

0.60

References per Document

26.83

Coverage

2017-2025

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago